(Q33554567)
Statements
1 reference
Pharmacokinetics of oritavancin in plasma and skin blister fluid following administration of a 200-milligram dose for 3 days or a single 800-milligram dose (English)
1 reference
Sujata M Bhavnani
1 reference
Paul G Ambrose
1 reference
Gerald J Fetterly
1 reference
Christine M Ong
1 reference
Jeffrey S Loutit
1 reference
Steven B Porter
1 reference
Lisa G Morello
1 reference
David P Nicolau
1 reference
1 January 2005
1 reference
1 reference
49
1 reference
148-152
1 reference
Identifiers
1 reference
1 reference
1 reference